- Features
- Performances
- Specifications
- References
Neurological diseases(e.g., Myasthenia gravis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)
- Therapeutic plasmapheresis by removing pathogenic substances (anti-acetylcholine receptor antibodies and immune complexes) from patient's plasma by selective adsorption.
- No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
- Applicable to patients with protein allergy.
Trademark
IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.
![](/medical/en/apheresis/product/plasma/tr/img/img_download.jpg)
IMMUSORBA TR
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.